A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes.

Diabetes technology & therapeutics

Volumn 12, Issue 6, 2010, Pages 419-425

  Alish, Carolyn J ^a   Garvey, W Timothy ^b   Maki, Kevin C ^b   Sacks, Gordon S ^b   Hustead, Deborah S ^b   Hegazi, Refaat A ^b   Mustad, Vikkie A ^b  

^a ABBOTT LABORATORIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPARAMETRIC TEST; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENTERAL NUTRITION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; POSTPRANDIAL PERIOD; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 77955902364     PISSN: None     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2009.0185     Document Type: Article

References (0)